500 mcg ipamorelin 4X Blend GHRP-2 (5mg) / Tesamorelin (5mg) / MGF (500mcg) / (2.5mg) BPC-157 (500 MCG) - Sigma

Cottam MA, Caslin HL, Winn NC, Hasty AH

Nonetheless, the posts are too brief for newbies

Ogasawara S

Science 216 , 13171319 (1982)

JTO (2007) 2:85461

The current strategies for exploration encompass various avenues: botanical research (identifying and characterizing novel cannabinoids present in different cannabis strains), synthetic chemistry (chemical synthesis enables the creation of cannabinoid analogs with desired therapeutic properties), metabolic engineering (modifying the biosynthetic pathways of cannabis plants encourages the production of specific novel cannabinoids), selectivity to receptor subtypes (identifying cannabinoids with specific receptor selectivity holds promise for more targeted therapies with fewer side effects), non-psychoactive cannabinoids (exploring cannabinoids devoid of THCs psychoactive effects while retaining therapeutic benefits broadens their potential applications and addresses concerns about misuse), water-soluble formulations (developing water-soluble cannabinoid formulations enhances bioavailability and facilitates administration through various routes) [8,97]